ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,644,000 | +29.2% | 9,554 | -5.7% | 0.01% | +40.0% |
| Q2 2021 | $1,272,000 | +0.1% | 10,135 | +8.1% | 0.01% | -79.2% |
| Q1 2021 | $1,271,000 | -2.2% | 9,373 | -7.8% | 0.05% | -2.0% |
| Q4 2020 | $1,300,000 | +13.7% | 10,161 | 0.0% | 0.05% | -2.0% |
| Q3 2020 | $1,143,000 | +29.2% | 10,161 | +9.4% | 0.05% | +22.0% |
| Q2 2020 | $885,000 | +26.4% | 9,290 | +19.2% | 0.04% | +141.2% |
| Q1 2020 | $700,000 | +65.1% | 7,792 | -2.5% | 0.02% | +112.5% |
| Q4 2019 | $424,000 | +38.6% | 7,991 | +3.2% | 0.01% | +33.3% |
| Q3 2019 | $306,000 | -5.3% | 7,746 | -1.4% | 0.01% | -25.0% |
| Q2 2019 | $323,000 | +11.8% | 7,854 | +26.6% | 0.01% | +14.3% |
| Q1 2019 | $289,000 | +19.4% | 6,205 | +11.7% | 0.01% | 0.0% |
| Q4 2018 | $242,000 | -13.9% | 5,556 | -4.1% | 0.01% | 0.0% |
| Q2 2018 | $281,000 | +29.5% | 5,795 | +13.5% | 0.01% | +16.7% |
| Q4 2017 | $217,000 | – | 5,107 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |